Living Cell Technologies Ltd. (AU:1AI) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Algorae Pharmaceuticals has appointed Dr. Sarah Siggins to its Scientific Advisory Board, a move expected to bolster its AI-driven drug discovery efforts. With her extensive experience at Johnson & Johnson and Bristol-Myers Squibb, Dr. Siggins is set to provide strategic advice on commercial partnerships for the company’s innovative therapies. This appointment marks a significant step in Algorae’s efforts to advance its pipeline of AI-generated drug candidates.
For further insights into AU:1AI stock, check out TipRanks’ Stock Analysis page.